2022 FIT Symposium: Networking and the Job Search

Save the Date! Cardiology Fellows-in-Training will have the opportunity to hear from some of Minnesota’s top cardiologists about their real-world experiences during the transition from training to practice. We will have a panel discussion for approximately 90 minutes, with time outside of that for questions and networking.

PANELISTS:

  • Catherine (Katie) Benziger, MD, MPH, FACC, FAHA – Essentia Health
  • Michelle Carlson, MD, FACC – Hennepin Healthcare
  • Selma Carlson, MD, FACC – Minneapolis VA & University of Minnesota Medical School
  • Jane Chen, MD, FACC, FHRS – University of Minnesota
  • Michael Cullen, MD, FACC – Mayo Clinic
  • Andrea Elliott, MD, FACC – University of Minnesota
  • William (Bill) Katsiyiannis, MD, FACC – Minneapolis Heart Institute
  • Sheetal (Sunny) Kaul, MD, MBBS, FACC – HealthPartners
  • Carmelo Panetta, MD, FACC – University of MN Physicians
  • Retu Saxena, MD, FACC – Minneapolis Heart Institute
  • Gautam R. Shroff, MBBS, FACC – Hennepin Healthcare
  • Mengistu A. Simegn, MD, FACC, FASE – Hennepin Healthcare
  • Stephen J. Smalley, MD, FACC – Essentia Health
  • Randall (Randy) Stark, MD, FACC – Metropolitan Heart & Vascular Institute
  • Sharath S. Subramanian, MBBS, MD, FACC – Centracare Heart & Vascular Center

CME Webinar: Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs

Program Overview:

Anemia in CKD is associated with poor CV outcomes, increased risk of CKD progression, decreased health-related quality of life (HRQOL), and increased healthcare resource utilization. Erythropoiesis-stimulating agents have been the standard of care for treating anemia in CKD but are associated with CV safety concerns; other therapies include red blood cell transfusions and iron administration, but each potentially has severe adverse events.

Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are promising novel agents in development for treating CKD-associated anemia. These oral agents increase endogenous erythropoietin production, improve iron absorption and mobilization, and decrease hepcidin production in the liver.

Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs will provide cardiologists with information about the etiology of anemia in CKD, the effects on CV disease, HRQOL, and function, advantages and limitations of current management strategies, and the efficacy and safety data for HIF-PHIs in late-stage development for the management of CKD-related anemia.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

  • Discuss the etiology of anemia in chronic kidney disease
  • Summarize how anemia affects functioning, quality of life, and health outcomes, for patients with cardiovascular disease and chronic kidney disease
  • Assess the benefits and limitations of available modalities for treating anemia in chronic kidney disease
  • Describe the mechanism of action of and efficacy and safety data for agents in late-stage development for the management of anemia of chronic kidney disease

Steering Committee:

Erin Michos, MD, MHS
Associate Professor of Medicine
Division of Cardiology
Johns Hopkins School of Medicine

Matthew Weir, MD
Professor and Chief
Division of Nephrology
Department of Medicine
University of Maryland School of Medicine

Jointly provided by USFH and Rockpointe.

This educational activity is supported by an educational grant from GlaxoSmithKline.

2022 FIT Symposium: Networking and the Job Search

Save the Date! Cardiology Fellows-in-Training will have the opportunity to hear from some of Minnesota’s top cardiologists about their real-world experiences during the transition from training to practice. We will have a panel discussion for approximately 90 minutes, with time outside of that for questions and networking.

PANELISTS:

Catherine (Katie) Benziger, MD, MPH, FACC, FAHA – Essentia Health
Michelle Carlson, MD, FACC – Hennepin Healthcare
Selma Carlson, MD, FACC – Minneapolis VA & University of Minnesota Medical School
Jane Chen, MD, FACC, FHRS – University of Minnesota
Michael Cullen, MD, FACC – Mayo Clinic
Andrea Elliott, MD, FACC – University of Minnesota
William (Bill) Katsiyiannis, MD, FACC – Minneapolis Heart Institute
Sheetal (Sunny) Kaul, MD, MBBS, FACC – HealthPartners
Carmelo Panetta, MD, FACC – University of MN Physicians
Retu Saxena, MD, FACC – Minneapolis Heart Institute
Gautam R. Shroff, MBBS, FACC – Hennepin Healthcare
Mengistu A. Simegn, MD, FACC, FASE – Hennepin Healthcare
Stephen J. Smalley, MD, FACC – Essentia Health
Randall (Randy) Stark, MD, FACC – Metropolitan Heart & Vascular Institute
Sharath S. Subramanian, MBBS, MD, FACC – Centracare Heart & Vascular Center

FIT Lecture Series: Mitral Valve Prolapse – When Does It Stop Being Benign? on Sept. 13

ACCMN FIT Lecture Series 09.13.22 Mitral Valve Prolapse and Mitral Annular Disjunction

Join us the second Tuesday of each month for our ongoing Fellows in Training (FIT) Lecture Series. On Tuesday, September 13th from 6-8 PM Iulia-Maria Tulai, M.D., Cardiology Fellow at the Minneapolis Heart Institute Foundation & Hennepin Healthcare, will present a talk on mitral valve prolapse.

This event is free, but registration is required. Register here and mark your calendars for the second Tuesday of every month to join us for future lectures.

FIT Lecture Series | Mitral Valve Prolapse – When Does It Stop Being Benign?

Join us the second Tuesday of each month for our new Fellows in Training (FIT) Lecture Series. These events are free, but registration is required. Register today and mark your calendar for the second Tuesday of every month to join us for future lectures.

On Tuesday, September 13th from 6-8 PM Central Iulia-Maria Tulai, M.D., a Cardiology Fellow at the Minneapolis Heart Institute Foundation & Hennepin Healthcare, will present a talk on Mitral Valve Prolapse and Mitral Annular Disjunction.

NEW FIT Lecture Series: Pericarditis on Aug. 9

Join us the second Tuesday of each month for our ongoing Fellows in Training (FIT) Lecture Series. On Tuesday, August 9th from 6-8pm Kathryn F. Larson, M.D., Chief Fellow in the Division of Cardiology at Mayo Clinic will present a talk on Pericarditis.

This event is free, but registration is required. Register here and mark your calendars for the second Tuesday of every month to join us for future lectures.

Kathryn F. Larson, M.D.

Presentation

Using a case-based format, we will review the basics of diagnosis, ancillary testing, and therapeutics for pericarditis. The talk will include a discussion of the 2015 ESC Guidelines on pericardial disease, as well as a brief overview of key pivotal trials in the management of pericarditis (both initial episodes and recurrence).

Professional Development Series – Meet the Inventor: How TAVI Was Born

Saturday, May 14th, 2022

10 a.m. Central | Zoom

While listening to Julio Palmaz speak at a conference in Scottsdale, Arizona in February 1989, Henning Rud Andersen was inspired to concept implanting heart valves percutaneously. Within 3 months, Dr. Andersen made and implanted the first transcatheter heart valve in an animal model. Today, TAVI is the main treatment of severe aortic stenosis in many parts of the world. Join Drs. Mohamad Alkhouli and David R. Holmes for a virtual conversation with Dr. Andersen about his extraordinary journey with TAVI.

Moderators: Mohamad Alkhouli MD, FACC and David Holmes MD

Guest: Henning Rud Andersen MD

View the event flyer here.

2022 FIT Echo Bootcamp Registration Now Open

Presented by the Iowa and Minnesota Chapters of the American College of Cardiology

Registration is now open for our third annual FIT Echo Bootcamp. Join other Fellows in Training for an in-depth study on Echocardiographic Examinations and Emergencies led by Dr. Rick Marcus of the Iowa Heart Center. This four-part virtual series will take place from 6-8 pm Central on July 5th, 7th, 12th and 14th. Visit the FIT Echo Bootcamp page for more information.